We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+11.32%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$851M
AUM Growth
+$67.4M
(+8.6%)
Cap. Flow
-$10.5M
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
34.66%
Holding
209
New
6
Increased
44
Reduced
115
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
New York Times
NYT
|
+$4.51M |
| 2 |
ZUO
Zuora, Inc.
ZUO
|
+$4.24M |
| 3 |
Amalgamated Financial
AMAL
|
+$1.01M |
| 4 |
IPG Photonics
IPGP
|
+$995K |
| 5 |
Abbott
ABT
|
+$606K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.12M |
| 2 |
J.M. Smucker
SJM
|
+$3.09M |
| 3 |
Procter & Gamble
PG
|
+$2.41M |
| 4 |
Xylem
XYL
|
+$1.67M |
| 5 |
Fortive
FTV
|
+$1.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.13% |
| 2 | Technology | 20.2% |
| 3 | Industrials | 13.02% |
| 4 | Financials | 10.76% |
| 5 | Communication Services | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Editas Medicine
EDIT
$453M
| – | – |
-5,650
| Closed | -$202K |
|
202
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| – | – |
-6,227
| Closed | -$270K |
|
203
Extra Space Storage
EXR
$31B
| – | – |
-2,201
| Closed | -$220K |
|
|
HOLX
204
DELISTED
Hologic
HOLX
| – | – |
-10,356
| Closed | -$412K |
|
|
MRSH
205
Marsh
MRSH
$91.3B
| – | – |
-3,450
| Closed | -$283K |
|
206
Snap-on
SNA
$21.3B
| – | – |
-5,079
| Closed | -$816K |
|
207
Travel + Leisure Co
TNL
$4.52B
| – | – |
-14,920
| Closed | -$661K |
|
208
Wyndham Hotels & Resorts
WH
$5.38B
| – | – |
-15,020
| Closed | -$884K |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
NIM
C
Reynders McVeigh Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Reynders McVeigh Capital Management held 209 positions worth $851M, up 8.6% from $784M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Reynders McVeigh Capital Management's Q3 2018 filing shows 6 new, 44 increased, 115 reduced and 8 closed positions. Its largest new stake was Zuora, Inc.: 158,922 shares worth $3.67M. The largest sale was Gilead Sciences, an estimated $3.12M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q3 2018 buy was Zuora, Inc.: 158,922 shares worth $3.67M.
- Reynders McVeigh Capital Management added most to New York Times in Q3 2018, an estimated $4.51M increase.
- Reynders McVeigh Capital Management's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $3.12M.
- Reynders McVeigh Capital Management fully exited Wyndham Hotels & Resorts in Q3 2018, selling an estimated $884K.
- Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $851M portfolio in Q3 2018.
- Reynders McVeigh Capital Management opened 6 new positions and closed 8 in Q3 2018.
- Reynders McVeigh Capital Management's portfolio value rose 8.6% quarter-over-quarter to $851M.
Based on Reynders McVeigh Capital Management's 13F filing for Q3 2018, filed 20 Nov 2018.